✦ LIBER ✦

Clinical pharmacology of oral intermediate-dose methotrexate with or without probenecid

✍ Scribed by Michael B. Lilly; George A. Omura

Publisher: Springer
Year: 1985
Tongue: English
Weight: 259 KB
Volume: 15
Category: Article
ISSN: 0344-5704
DOI: 10.1007/bf00263889

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized comparison of moderate-dose m

Randomized comparison of moderate-dose methotrexate infusions to oral methotrexate in children with intermediate risk acute lymphoblastic leukemia: A Childrens Cancer Group study

✍ Lange, Beverly J.; Blatt, Julie; Sather, Harland N.; Meadows, Anna T. 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 559 KB

Methotrexate (MTX) infusions of 500-1,000 mg/m2 over 24 hours may improve survival and prevent relapse in children with acute lymphoblastic leukemia (ALL). Childrens Cancer Group (CCG) Study 139 compared weekly oral methotrexate 20 mg/m2/ week (oral MTX) to MTX 500 mg/m2 infused over 24 hours (IV MT

Randomized, placebo-controlled, crossove

Randomized, placebo-controlled, crossover trial of low-dose oral methotrexate in children with extended oligoarticular or systemic arthritis

✍ P. Woo; T. R. Southwood; A.-M. Prieur; C. J. Doré; J. Grainger; J. David; C. Ryd 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB 👁 2 views

The pharmacologic activity of complexes

The pharmacologic activity of complexes and mixtures with copper and salicylates or aminopyrine following oral dosing in rats

✍ Z. Korolkiewicz; E. Hać; I. G⇓gało; P. Gorczyca; A. łodzińska 📂 Article 📅 1989 🏛 SP Birkhäuser Verlag Basel 🌐 English ⚖ 366 KB

Clinical hyperthermia: Results of the ph

Clinical hyperthermia: Results of the phase i clinical trial combining localized hyperthermia with or without radiation (high dose rate and low dose rate)

✍ Michael R. Manning; Thomas Cetas; Max L.M. Boone; Robert C. Miller 📂 Article 📅 1979 🏛 Elsevier Science 🌐 English ⚖ 107 KB

Cyclophosphamide, vincristine, adriamyci

Cyclophosphamide, vincristine, adriamycin, and prednisone (CHOP) with and without intermediate dose methotrexate for the treatment of non-Hodgkin's lymphomas of diffuse histology

✍ German A. Gomez; Maurice Barcos; Tin Han; Edward S. Henderson 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 702 KB

Phase II trial of intermediate dose meth

Phase II trial of intermediate dose methotrexate in combination with vinblastine, doxorubicin, and cisplatin in patients with unresectable or metastatic transitional cell carcinoma

✍ Paul M. Dodd; John A. McCaffrey; Madhu Mazumdar; Howard Scher; Vaia Vlamis; Gera 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB 👁 3 views

## Background: This study was undertaken to determine whether the use of intermediate dose methotrexate in combination with vinblastine, doxorubicin, and cisplatin as first-line therapy increases the proportion of major responders and overall survival in patients with unresectable or metastatic tra